But even a tiny benefit, restricted to skin cancers in healthy male doctors—but not prostate cancers, alas—is good news for the supplement industry. Supplement sellers are eager to make sure you don’t miss this research.
The study results came out on October 18. Pfizer, the maker of the Centrum Silver pills used in the study, placed this ad in the New York Times on October 19:
But that’s not all. CVS pharmacy sent me this personal e-mail message:
Pfizer, of course, could not be happier.
Why do I think this is about marketing, not public health?
Next public appearance
New Directions in the Fight Against Hunger and Malnutrition: A Festschrift in Honor of Per Pinstrup-Andersen. Cornell University, Statler Hotel Amphitheater. The conference begins at 7:30 a.m. with breakfast and ends with a reception the following day with remarks by professor Pinstrup-Andersen at 2:25 p.m. For the schedule and details, click here.
My joint contribution with Malden Nesheim is from 1:40-2:00 p.m. on “the internationalization of the obesity epidemic: the case of sugar-sweetened sodas.”